Ginkgolide B
Alternative Names: BN 52021Latest Information Update: 30 Aug 2004
Price :
$50 *
At a glance
- Originator Ipsen
- Developer Ipsen; Nonindustrial sources
- Class Lactones; Small molecules
- Mechanism of Action Immunosuppressants; Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Arterial thrombosis; Asthma; Cancer; Gram-negative infections; Ischaemic heart disorders; Lung transplant rejection; Multiple sclerosis; Peptic ulcer; Renal transplant rejection; Septic shock; Xenotransplant rejection
Most Recent Events
- 17 Nov 2002 Discontinued - Preclinical for Cancer in France (unspecified route)
- 17 Nov 2002 Discontinued for Cancer in Hungary (unspecified route)
- 14 Nov 2002 Discontinued - phase III for Septic shock in Europe (IV)